J Martínez-Beltrán

1.9k total citations
39 papers, 1.6k citations indexed

About

J Martínez-Beltrán is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, J Martínez-Beltrán has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Medicine, 19 papers in Pharmacology and 15 papers in Epidemiology. Recurrent topics in J Martínez-Beltrán's work include Antibiotic Resistance in Bacteria (26 papers), Antibiotics Pharmacokinetics and Efficacy (19 papers) and Pneumonia and Respiratory Infections (9 papers). J Martínez-Beltrán is often cited by papers focused on Antibiotic Resistance in Bacteria (26 papers), Antibiotics Pharmacokinetics and Efficacy (19 papers) and Pneumonia and Respiratory Infections (9 papers). J Martínez-Beltrán collaborates with scholars based in Spain, United Kingdom and Germany. J Martínez-Beltrán's co-authors include Germán Bou, Antonio Oliver, M.Á. Domínguez, Carmen Quereda, Fernando Baquero, Antonio Guerrero, Emilio Bouza, J C Pérez-Díaz, C. Quereda and Rafael Cantón and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

J Martínez-Beltrán

39 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Martínez-Beltrán Spain 17 1.1k 529 392 386 377 39 1.6k
C. Chanal France 26 1.8k 1.6× 731 1.4× 426 1.1× 409 1.1× 540 1.4× 47 2.0k
R. Jungwirth Germany 17 1.1k 1.0× 487 0.9× 366 0.9× 342 0.9× 430 1.1× 25 1.5k
V. Krčméry Slovakia 12 841 0.7× 314 0.6× 224 0.6× 389 1.0× 245 0.6× 99 1.3k
M Visalli United States 20 946 0.8× 254 0.5× 613 1.6× 538 1.4× 370 1.0× 32 1.6k
María‐Isabel Morosini Spain 26 946 0.8× 361 0.7× 295 0.8× 446 1.2× 459 1.2× 55 1.6k
Amal Karim France 11 1.1k 1.0× 559 1.1× 195 0.5× 225 0.6× 435 1.2× 11 1.3k
R Cluzel France 17 800 0.7× 330 0.6× 321 0.8× 247 0.6× 237 0.6× 69 1.1k
Christine Lascols France 25 1.2k 1.1× 544 1.0× 349 0.9× 454 1.2× 297 0.8× 44 2.1k
M. H. Nicolas France 16 2.0k 1.8× 894 1.7× 497 1.3× 491 1.3× 502 1.3× 32 2.4k
Marie-France I. Palepou United Kingdom 16 1.4k 1.2× 638 1.2× 411 1.0× 265 0.7× 522 1.4× 17 1.8k

Countries citing papers authored by J Martínez-Beltrán

Since Specialization
Citations

This map shows the geographic impact of J Martínez-Beltrán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Martínez-Beltrán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Martínez-Beltrán more than expected).

Fields of papers citing papers by J Martínez-Beltrán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Martínez-Beltrán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Martínez-Beltrán. The network helps show where J Martínez-Beltrán may publish in the future.

Co-authorship network of co-authors of J Martínez-Beltrán

This figure shows the co-authorship network connecting the top 25 collaborators of J Martínez-Beltrán. A scholar is included among the top collaborators of J Martínez-Beltrán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Martínez-Beltrán. J Martínez-Beltrán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jl, Alvarez-Sala, et al.. (2006). Clinical and Bacteriological Efficacy in Treatment of Acute Exacerbations of Chronic Bronchitis with Cefditoren-Pivoxil versus Cefuroxime-Axetil. Antimicrobial Agents and Chemotherapy. 50(5). 1762–1767. 42 indexed citations
2.
Reinoso, Javier Cobo, et al.. (2002). Evaluación de un programa de asesoría en terapia antibiótica. Revista Clínica Española. 202(2). 78–83. 19 indexed citations
3.
Fortün, Jesús, Enrique Navas, J Martínez-Beltrán, et al.. (2001). Short‐Course Therapy for Right‐Side Endocarditis Due toStaphylococcus aureusin Drug Abusers: Cloxacillin versus Glycopeptides in Combination with Gentamicin. Clinical Infectious Diseases. 33(1). 120–125. 78 indexed citations
4.
5.
6.
Bou, Germán, Antonio Oliver, & J Martínez-Beltrán. (2000). OXA-24, a Novel Class D β-Lactamase with Carbapenemase Activity in an Acinetobacter baumannii Clinical Strain. Antimicrobial Agents and Chemotherapy. 44(6). 1556–1561. 215 indexed citations
7.
Casado, José L., et al.. (1999). Zidovudine Therapy Protects againstSalmonellaBacteremia Recurrence in Human Immunodeficiency Virus–Infected Patients. The Journal of Infectious Diseases. 179(6). 1553–1556. 28 indexed citations
8.
Vilà, Jordi, Joaquı́m Ruiz, Margarita M. Navia, et al.. (1999). Spread of Amikacin Resistance in Acinetobacter baumannii Strains Isolated in Spain Due to an Epidemic Strain. Journal of Clinical Microbiology. 37(3). 758–761. 51 indexed citations
9.
Baquero, Fernando, J Martínez-Beltrán, & Rafael Cantón. (1998). [Criteria of the MENSURA group for the definition of the critical points of sensitivity to antibiotics].. PubMed. 16(2). 85–92. 14 indexed citations
10.
Valdezate, Sylvia, J Martínez-Beltrán, Luis Rafael, Fernando Baquero, & Rafael Cantón. (1996). β-Lactam stability in frozen microdilution PASCO MIC panels using strains with known resistance mechanisms as biosensors. Diagnostic Microbiology and Infectious Disease. 26(2). 53–61. 13 indexed citations
11.
Martínez-Beltrán, J, Rafael Cantón, Josefina Liñares, et al.. (1995). Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin. European Journal of Clinical Microbiology & Infectious Diseases. 14(3). 244–252. 6 indexed citations
12.
Morosini, M.I., Rafael Cantón, J Martínez-Beltrán, et al.. (1995). New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak. Antimicrobial Agents and Chemotherapy. 39(2). 458–461. 52 indexed citations
13.
Pérez-Díaz, J C, Juan A. Ayala, José María Casellas, et al.. (1994). Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants. Antimicrobial Agents and Chemotherapy. 38(9). 2150–2157. 96 indexed citations
14.
Baquero, Fernando, Rafael Cantón, J Martínez-Beltrán, & Anne Bolmström. (1992). The E-Test as an epidemiologic tool. Diagnostic Microbiology and Infectious Disease. 15(5). 483–487. 15 indexed citations
15.
Baquero, Fernando, et al.. (1991). The Incidence and Beta-lactam Resistance ofProteus vulgarisin Hospital Infections: the Last Decade. Journal of Chemotherapy. 3(5). 283–288. 1 indexed citations
16.
Bouza, Emilio, et al.. (1983). Evaluation of ceftazidime in the treatment of severe bacterial infection. Journal of Antimicrobial Chemotherapy. 12(suppl A). 153–159. 8 indexed citations
17.
Bouza, Emilio, et al.. (1983). Evaluation of Lamoxactam in the Treatment of Severe Bacterial Infections. Chemotherapy. 29(5). 373–383. 3 indexed citations
18.
Burgaleta, Carmen, J Martínez-Beltrán, & Emilio Bouza. (1982). Comparative effects of moxalactam and gentamicin on human polymorphonuclear leukocyte functions. Antimicrobial Agents and Chemotherapy. 21(5). 718–720. 10 indexed citations
19.
Bouza, Emilio, M. A. Meseguer, Luís Buzón, et al.. (1980). Yersinia enterocolitica Septicemia. American Journal of Clinical Pathology. 74(4). 404–409. 77 indexed citations
20.
Martínez-Beltrán, J, et al.. (1976). Preliminary Clinical Trial with Amikacin in Chronic Recurrent Gram-Negative Bacterial Infections Refractory to Other Antimicrobial Agents. The Journal of Infectious Diseases. 134(Supplement 2). S381–S383. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Chanal Breakdown of academic impact, for papers by R. Jungwirth Breakdown of academic impact, for papers by V. Krčméry Breakdown of academic impact, for papers by M Visalli Breakdown of academic impact, for papers by María‐Isabel Morosini Breakdown of academic impact, for papers by Amal Karim Breakdown of academic impact, for papers by R Cluzel Breakdown of academic impact, for papers by Christine Lascols Breakdown of academic impact, for papers by M. H. Nicolas Breakdown of academic impact, for papers by Marie-France I. Palepou
Rankless by CCL
2026